Survival of Neuroblastoma Patients Treated by Long-Term Infusion of Anti-GD2 Antibody CH14.18/CHO Correlate with Killer-Cell Ig-Like Receptor (KIR) Genotypes and Fc gamma-Receptor Polymorphisms

Lode H.; Troschke-Meurer S.; Valteau-Couanet D.; Garaventa A.; Gray J.; Castel V.; Yaniv I.; Siebert N.; Eger C.; Juettner M.; Kietz S.; Karoline E.; Janzek E.; Loibner H.; Mueller I.; Ladenstein R.

首页> 外文期刊>Pediatric blood & cancer >Survival of Neuroblastoma Patients Treated by Long-Term Infusion of Anti-GD2 Antibody CH14.18/CHO Correlate with Killer-Cell Ig-Like Receptor (KIR) Genotypes and Fc gamma-Receptor Polymorphisms

【24h】

Survival of Neuroblastoma Patients Treated by Long-Term Infusion of Anti-GD2 Antibody CH14.18/CHO Correlate with Killer-Cell Ig-Like Receptor (KIR) Genotypes and Fc gamma-Receptor Polymorphisms

机译：长期输注抗GD2抗体CH14.18 / CHO治疗的神经母细胞瘤患者的存活与杀伤细胞Ig样受体（KIR）基因型和Fcγ受体多态性相关

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer 》 |2016年第3期| 共1页
作者
Lode H.; Troschke-Meurer S.; Valteau-Couanet D.; Garaventa A.; Gray J.; Castel V.; Yaniv I.; Siebert N.; Eger C.; Juettner M.; Kietz S.; Karoline E.; Janzek E.; Loibner H.; Mueller I.; Ladenstein R.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Survival of Neuroblastoma Patients Treated by Long-Term Infusion of Anti-GD2 Antibody CH14.18/CHO Correlate with Killer-Cell Ig-Like Receptor (KIR) Genotypes and Fc gamma-Receptor Polymorphisms [J] . Lode H., Troschke-Meurer S., Valteau-Couanet D., Pediatric blood & cancer . 2016 ,第Suppla3期

机译：长期输注抗GD2抗体CH14.18 / CHO治疗的神经母细胞瘤患者的存活与杀伤细胞Ig样受体（KIR）基因型和Fcγ受体多态性相关
2. Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients [J] . Holger Lode, Nikolai Siebert, Silke Kietz, Journal for ImmunoTherapy of Cancer . 2013 ,第S1期

机译：复发/难治性神经母细胞瘤患者长期连续输注抗GD2抗体CH14.18 / CHO
3. Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients [J] . Holger Lode, Nikolai Siebert, Silke Kietz, Journal for ImmunoTherapy of Cancer . 2013 ,第S1期

机译：在复发/难治性神经母细胞瘤患者中长期连续输注抗GD2抗体CH14.18 / CHO
4. Neuroblastoma patients with high-affinity FCGR2A -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD2 antibody ch14.18/CHO show higher ADCC levels and improved event-free survival [O] . Nikolai Siebert, Christian Jensen, Sascha Troschke-Meurer, 2016

机译：长期输注抗GD2抗体ch14.18 / CHO治疗的具有高亲和力FCGR2A-3A和刺激性KIR 2DS2的神经母细胞瘤患者显示更高的ADCC水平和改善的无事件生存
5. Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients [O] . Holger Lode, Nikolai Siebert, Silke Kietz, 2013

机译：复发/难治性神经母细胞瘤患者长期连续输注抗GD2抗体CH14.18 / CHO

Survival of Neuroblastoma Patients Treated by Long-Term Infusion of Anti-GD2 Antibody CH14.18/CHO Correlate with Killer-Cell Ig-Like Receptor (KIR) Genotypes and Fc gamma-Receptor Polymorphisms

著录项

相似文献

相关主题

期刊订阅